infections
William Fusco, gastroenterologist at Policlinico Universitario Agostino Gemelli, highlighted a recently published pilot study on post-infectious irritable bowel syndrome (IBS) framed within microbial precision medicine and biomarker-driven care.
Immunology
Sponsored by
Three infant-derived strains isolated and developed by Coree srl that are potentially interesting for immune support.
Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.
The findings of a recent study highlight the importance of understanding skin microbiotas to manage long-term fungal infections in Indigenous communities.
A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.
A recent study highlights the potential for dietary interventions in treating C. difficile infection and inflammatory conditions such as inflammatory bowel disease.
Industry
Sponsored by
A new scientific publication on the beneficial effect of probiotics on cold symptoms relief, immune response enhancement, and quality of life in healthy adults during winter seasons.
Targeting TudS could be a potential therapeutic approach for treating C. difficile infections.
Targeting E. lenta or boosting neutrophil function may lead to new treatment strategies for bronchiectasis and related lung diseases.
Nutrient competition is the main mechanism of C. difficile inhibition, hinting at the potential for targeted therapies with probiotics instead of traditional FMT.
